Order results by:
| Issue | Title | |
| Vol 10, No 1 (2014) | MULTIFACTOR PRIMARY PREVENTION OF ISCHEMIC HEART DISEASE IN MIDDLE-AGED MEN AND ITS EFFICACY (10-YEAR FOLLOW-UP) | Abstract PDF (Eng) similar documents |
| A. M. Kalinina | ||
| "... follow-up exceed the risk predicted by the SCORE chart. Active primary IHD prevention allows to reduce ..." | ||
| Vol 9, No 2 (2013) | TREATMENT OF PATIENTS WITH CHRONIC ISCHEMIC HEART DISEASE IN REAL CLINICAL PRACTICE ACCORDING TO THE DATA FROM PROGNOZ IBS REGISTER. (Part 1) | Abstract similar documents |
| S. N. Tolpygina, Yu. N. Polyanskaya, S. Yu. Martsevich | ||
| "... According to the data from PROGNOZ IBS register drugs with proven efficacy in secondary prevention ..." | ||
| Vol 8, No 4 (2012) | UP TO DATE STATINS IN PRIMARY AND SECONDARY PREVENTION OF CARDIOVASCULAR DISEASES | Abstract similar documents |
| N. F. Puchin'yan, Ya. P. Dovgalevskiy, A. V. Panina | ||
| "... components according to multifactor origin of cardiovascular disease (CVD). Correction of lipid metabolism ..." | ||
| Vol 10, No 5 (2014) | OUTPATIENT REGISTRY OF CARDIOVASCULAR DISEASES (RECVASA): PROSPECTIVE FOLLOW-UP DATA, ESTIMATION OF RISKS AND OUTCOMES IN PATIENTS WITH ATRIAL FIBRILLATION | Abstract PDF (Eng) similar documents |
| M. M. Loukianov, S. A. Boytsov, S. S. Yakushin, S. Yu. Martsevich, A. N. Vorobyev, A. V. Zagrebelnyy, M. S. Kharlap, K. G. Pereverzeva, E. A. Pravkina, S. E. Serdyuk, A. D. Deev, E. N. Kudryashov | ||
| "... ) within 12 months of follow-up in actual outpatient practice. Material and methods. A total of 3690 ..." | ||
| Vol 10, No 2 (2014) | PRIMARY PREVENTION OF MYOCARDIAL INFARCTION IN MIDDLE-AGED MALES (15-YEAR FOLLOW-UP): CLINICAL AND ECONOMIC ASPECTS OF THE PROBLEM | Abstract PDF (Eng) similar documents |
| A. M. Kalinina, A. V. Kontsevaya | ||
| "... -aged men during 15-year follow-up; to evaluate economic efficiency of primary medical prevention ..." | ||
| Vol 15, No 6 (2019) | Association of Family History of Cardiovascular Diseases in Boys Aged 12-13 Years with Structural and Functional Indicators of the Left Ventricle and Arterial Stiffness in the Age of 43-46 Years (Results of 32-Year Prospective Follow-up) | Abstract similar documents |
| O. Yu. Isaykina, V. B. Rozanov, A. A. Aleksandrov, I. V. Leontyeva, M. B. Kotova, E. I. Ivanova | ||
| "... Aim. To evaluate the association of Family History (FH) of cardiovascular diseases (CVD) in boys ..." | ||
| Vol 15, No 5 (2019) | Patients with History of Myocardial Infarction and Acute Cerebrovascular Accidentin Clinical Practice: Demographic, Clinical Characteristics, Drug Treatment and Outcomes (Data of Outpatient and Hospital Registry REGION) | Abstract similar documents |
| E. Yu. Okshina, M. M. Loukianov, S. Yu. Martsevich, S. S. Yakushin, N. P. Kutishenko, A. N. Vorobyev, K. G. Pereverzeva, A. V. Zagrebelnyy, V. P. Voronina, N. A. Dmitrieva, O. V. Lerman, E. V. Kudryashov, S. A. Boytsov, O. M. Drapkina | ||
| "... ”). The incidence of cardiovascular diseases (CVD), non-CVD comorbidities, drug therapy and outcomes were analyzed ..." | ||
| Vol 16, No 5 (2020) | Possible Approaches to Primary Prevention of Cardiovascular Diseases | Abstract similar documents |
| V. N. Larina, D. S. Mkrtychev, V. A. Kuznetsova, A. A. Tyazhelnikov | ||
| "... , primary prevention of diseases. However, in most cases, patients seek help from a doctor after ..." | ||
| Vol 1, No 2 (2005) | STATINES IN PREVENTION AND TREATMENT OF ATHEROSCLEROSIS CONNECTED DISEASES: EFFICIENCY AND SAFETY | Abstract similar documents |
| Y. A. Karpov | ||
| "... prescription for primary and secondary prevention of cardiovascular diseases, including IHD and ischemic stroke ..." | ||
| Vol 19, No 1 (2023) | The Study of Adherence to Drug Therapy at the Stage of Outpatient Follow-up in Patients with Acute Myocardial Infarction (Data from the PROFIL-IM Registry) | Abstract similar documents |
| E. P. Kalaydzhyan, N. P. Kutishenko, Yu. V. Lukina, D. P. Sichinava, S. Yu. Martsevich, O. M. Drapkina | ||
| "... Aim. To assess adherence to the recommended therapy at the stage of outpatient follow-up and its ..." | ||
| Vol 7, No 4 (2011) | GENDER DIFFERENCES IN THE EFFICACY OF RISK FACTORS CORRECTION AND TREATMENT COMPLIANCE IN PATIENTS AFTER ACUTE CORONARY SYNDROME | Abstract similar documents |
| A. Y. Efanov, D. F. Nizamova, E. F. Dorodneva, I. V. Medvedev, S. V. Shalaev | ||
| "... prevalence of cardiovascular risk factors requires intensification of preventive activity regarding IHD onset ..." | ||
| Vol 7, No 6 (2011) | EXPERIENCE OF «SCHOOL OF HEALTH» AND A ROLE OF THE GENERAL PRACTITIONER IN THE STRUGGLE WITH RISK FACTORS OF ISCHEMIC HEART DISEASE | Abstract similar documents |
| N. M. Nurillaeva, A. G. Gadaev | ||
| "... Aim. To study dynamics of risk factors of ischemic heart disease (IHD) in patients trained ..." | ||
| Vol 7, No 3 (2011) | EFFECT OF THERAPEUTIC TRAINING AND ACTIVE OUTPATIENT MANAGEMENT ON CLINICAL STATE AND CARDIOVASCULAR COMPLICATIONS IN PATIENTS WITH CHRONIC HEART FAILURE (THREE YEAR FOLLOW-UP) | Abstract similar documents |
| A. P. Rebrov, N. A. Kosheleva | ||
| "... on clinical state and cardiovascular complications (CVC) in patients with chronic heart failure ..." | ||
| Vol 16, No 1 (2020) | Patients with Combination of Cardiovascular Diseases and Type 2 Diabetes in RECVASA and REGION Registries: Multimorbidity, Outcomes and Potential Effect of Dapagliflozin in the Russian Clinical Practice | Abstract similar documents |
| M. M. Loukianov, A. V. Kontsevaya, A. O. Myrzamatova, M. B. Khudyakov, E. Y. Okshina, E. V. Kudryashov | ||
| "... of dapagliflozin in patients with a combination of cardiovascular disease (CVD) and type 2 diabetes in Russian ..." | ||
| Vol 14, No 1 (2018) | SMOKING AS A RISK FACTOR FOR CARDIOVASCULAR AND CEREBROVASCULAR DISEASES: PREVALENCE, IMPACT ON PROGNOSIS, POSSIBLE SMOKING CESSATION STRATEGIES AND THEIR EFFECTIVENESS. Part 2. Advantages of quitting smoking. Strategies to quit smoking | Abstract similar documents |
| O. D. Ostroumova, I. I. Kopchjonov, T. F. Guseva | ||
| "... quitting smoking the ischemic heart disease (IHD) risk will be 2 folds lower than the risk in smoking ..." | ||
| Vol 9, No 4 (2013) | STATINS IN PREVENTION OF ISCHEMIC STROKE | Abstract similar documents |
| A. V. Susekov, A. B. Blohin, Z. G. Luginova, E. J. Soloveva, N. V. Maltseva, O. E. Tarasova, V. V. Kuharchuk | ||
| "... The evidence base of statin therapy in primary and secondary prevention of ischemic stroke ..." | ||
| Vol 5, No 4 (2009) | PRIMARY PREVENTION OF CARDIOVASCULAR COMPLICATIONS: VALUE OF STATINS | Abstract similar documents |
| S. Y. Martsevich, N. P. Kutishenko | ||
| "... The definition of primary prevention of cardiovascular diseases is presented. Statins preventive ..." | ||
| Vol 18, No 5 (2022) | Clinical and Anamnestic Characteristics, Cardiovascular Pharmacotherapy and Long-term Outcomes in Multimorbid Patients after COVID-19 | Abstract similar documents |
| A. A. Smirnov, M. M. Loukianov, S. Yu. Martsevich, A. A. Pulin, N. P. Kutishenko, E. Yu. Andreenko, V. P. Voronina, V. A. Dindikova, N. A. Dmitrieva, M. M. Kudryavtseva, O. V. Lerman, A. N. Makoveeva, E. Yu. Okshina, A. A. Maltseva, E. N. Belova, V. G. Klyashtorniy, E. V. Kudryashov, O. E. Karpov, O. M. Drapkina | ||
| "... cardiovascular pharmacotherapy during the follow-up period decreased from 56.8% to 51.3% (p for trend = 0 ..." | ||
| Vol 14, No 3 (2018) | CARDIOPROTECTIVE PROPERTIES OF LISINOPRIL: NEW POSSIBILITIES | Abstract similar documents |
| V. I. Podzolkov, A. I. Tarzimanova, R. G. Gataulin | ||
| "... of lisinopril with hydrochlorothiazide over the 5-year follow-up; patients of group 2 (control) did not receive ..." | ||
| Vol 14, No 2 (2018) | ECONOMIC BURDEN OF CARDIOVASCULAR DISEASES IN THE RUSSIAN FEDERATION IN 2016 | Abstract PDF (Eng) similar documents |
| A. N. Kontsevaya, O. M. Drapkina, Yu. A. Balanova, A. E. Imaeva, E. I. Suvorova, M. B. Khudyakov | ||
| "... Aim. To evaluate the economic burden of cardiovascular diseases (CVD) in the Russian Federation ..." | ||
| Vol 20, No 2 (2024) | Remote active monitoring of patients after myocardial infarction: are there any advantages over standard outpatient monitoring? | Abstract similar documents |
| D. Yu. Sedykh, T. S. Alkhimova, V. V. Kashtalap, O. L. Barbarash | ||
| "... to therapy and regular outpatient follow-up, achieving target parameters of cardiovascular health ..." | ||
| Vol 14, No 2 (2018) | REGISTRY OF ACUTE CEREBRAL CIRCULATORY DISORDERS LIS-2: NEW DATA ON LONG-TERM FOLLOW-UP | Abstract similar documents |
| S. Yu. Martsevich, N. P. Kutishenko, A. V. Zagrebelnyy, Yu. V. Lukina, М. L. Ginzburg, A. V. Fokina, E. V. Daniels, A. D. Deev | ||
| "... after discharge, median follow-up 6.1 [6.9; 7.7] years. The primary endpoint was total mortality ..." | ||
| Vol 14, No 2 (2018) | DOCTOR’S ADHERENCE TO RECOMMENDATIONS GOVERNING THE ANTIPLATELET AGENTS USE IN THE CARDIOVASCULAR DISEASES PREVENTION AND TREATMENT | Abstract similar documents |
| N. В. Perepech, A. V. Tregubov | ||
| "... for primary and secondary prevention of cardiovascular diseases. 276 questionnaires filled out by 185 ..." | ||
| Vol 8, No 1 (2012) | PHARMACOECONOMIC EVALUATION OF DABIGATRAN VS WARFARIN IN CARDIOVASCULAR EVENTS PREVENTION IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION | Abstract similar documents |
| Yu. B. Belousov, V. Yu. Mareev, I. S. Yavelov, D. Yu. Belousov | ||
| "... embolism prevention in patients with atrial fibrillation (AF). Aim. Based on the RE-LY study to evaluate ..." | ||
| Vol 11, No 1 (2015) | VASCULAR COMORBIDITY: GENERAL APPROACHES TO PREVENTION AND TREATMENT | Abstract PDF (Eng) similar documents |
| R. G. Oganov | ||
| "... on the cardiovascular risk, general causes and approaches to the prevention and treatment of vascular comorbidity ..." | ||
| Vol 14, No 6 (2018) | Correction of Hypercholesterolemia in Primary and Secondary Prevention of Cardiovascular Diseases: Features and Controversial Issues | Abstract PDF (Eng) similar documents |
| N. M. Akhmedzhanov, D. V. Nebieridze, A. S. Safaryan | ||
| "... attention is paid to the use of statins in the primary prevention of cardiovascular complications ..." | ||
| Vol 20, No 6 (2024) | Medical treatment of cardiovascular diseases in patients after hospitalization for COVID-19 (three-year follow-up data in the TARGET-VIP registry) | Abstract similar documents |
| N. P. Kutishenko, S. Yu. Martsevich, M. M. Loukianov, E. Yu. Andreenko, V. P. Voronina, V. A. Dindikova, N. A. Dmitrieva, M. M. Kudryavtseva, O. V. Lerman, E. Yu. Okshina, A. A. Smirnov, A. G. Soplenkova, A. A. Pulin, N. N. Kuzina, D. A. Nefedova, V. G. Klyashtorniy, O. E. Karpov, O. M. Drapkina | ||
| "... Aim. To evaluate the quality of drug treatment of patients with cardiovascular diseases (CVD ..." | ||
| Vol 1, No 3 (2005) | EUROPEAN GUIDELINES ON CARDIOVASCULAR DISEASE PREVENTION IN CLINICAL PRACTICE | Abstract similar documents |
| G. De Backer, E. Ambrosioni, K. Borch-Johnsen, C. Brotons, R. Cifkova, J. Dallongeville, S. Ebrahim, O. Faergeman, I. Graham, G. Mancia, V. Manger Cats, K. Orth-Gomer, J. Perk, K. Pyorala, J. Rodicio, S. Sans, V. Sansoy, U. Sechtem, S. Silber, T. Thomsen, D. Wood | ||
| "... European guidelines on cardiovascular disease prevention in clinical practice. ..." | ||
| Vol 19, No 3 (2023) | Nutraceutical support in the prevention and treatment of cardiovascular diseases | Abstract similar documents |
| E. V. Gracheva, E. A. Starovoytova, E. S. Kulikov, N. A. Kirillova, S. V. Fedosenko, M. A. Balaganskaya, D. V. Kromka | ||
| "... Cardiovascular disease is the most common cause of death worldwide. In this regard ..." | ||
| Vol 20, No 6 (2024) | The impact of clinical decision support systems on adherence to clinical guidelines and achieving target levels of low-density lipoprotein cholesterol in patients at risk of developing cardiovascular events (SuccESS) | Abstract similar documents |
| K. S. Astrakova (Benimetskaya), I. L. Mikheenko, A. E. Uranov, A. A. Gartung, E. A. Kovalev, A. A. Spiridonov, I. I. Shestova, I. L. Strokolskaya, M. A. Meshkova, L. I. Esev, А. V. Reznik, V. А. Petrakovskaia, A. M. Shangina, Yu. E. Efremova, I. V. Sergienko, M. V. Ezhov, O. L. Barbarash, P. N. Paleev | ||
| "... hospitalized for acute cardiovascular events (CVEs), in patients with coronary artery disease (CAD ..." | ||
| Vol 5, No 2 (2009) | DOCTOR INERTNESS AS A FACTOR DISTURBING EFFECTIVE TREATMENT OF CARDIOVASCULAR DISEASES | Abstract similar documents |
| E. V. Minakov, R. A. Khokhlov, G. I. Furmenko, N. M. Akhmedzhanov | ||
| "... which treat and follow-up patients with cardiovascular diseases (CVD). Material and methods ..." | ||
| Vol 13, No 2 (2017) | ORAL ANTICOAGULANTS IN AMBULATORY AND IN-HOSPITAL TREATMENT OF PATIENTS WITH ATRIAL FIBRILLATION ASSOCIATED WITH HYPERTENSION, ISCHEMIC HEART DISEASE AND CHRONIC HEART FAILURE: DATA FROM HOSPITAL REGISTRY RECVASA-CLINIC | Abstract PDF (Eng) similar documents |
| E. V. Stepina, M. M. Loukianov, M. A. Bichurina, E. N. Belova, E. V. Kudryashov, Ju. V. Uzkov, S. A. Boytsov | ||
| "... of follow-up in patients with AF combined with HT, IHD and CHF comparing with in-hospital period (40 ..." | ||
| Vol 12, No 6 (2016) | EFFICIENCY OF INFLUENZA VACCINATION IN PATIENTS WITH CIRCULATORY SYSTEM DISEASES UNDER DISPENSARY OBSERVATION IN OUTPATIENT CLINICS: PROSPECTIVE FOLLOW-UP MONITORING DATA | Abstract similar documents |
| S. A. Boytsov, M. M. Loukianov, E. V. Platonova, V. M. Gorbunov, S. V. Romanchuk, O. A. Nazarova, O. A. Belova, E. A. Kravtsova, P. Ya. Dovgalevsky, N. V. Furman, A. A. Mironova, P. V. Dolotovskaya, A. V. Nekrasov, N. G. Puchkova, M. A. Abramova, E. N. Belova, V. G. Klyashtorny, A. D. Deev | ||
| "... diseases diseases (CSD) under 3-year follow-up in outpatient clinics. Methods. The efficiency of influenza ..." | ||
| Vol 9, No 4 (2013) | REAL PRACTICE OF STATINS USE AND ITS DEPENDENCE ON FOLLOW-UP IN THE SPECIALIZED MEDICAL CENTRE IN PATIENTS WITH HIGH CARDIOVASCULAR RISK (ACCORDING TO THE PROFILE REGISTER) | Abstract similar documents |
| S. Yu. Martsevich, O. V. Gaisenok, S. G. Tripkosh, Yu. V. Lukina, A. V. Zagrebel’nyy | ||
| "... Aim. To analyze tactics of statins use in patients with high cardiovascular risk on the base ..." | ||
| Vol 6, No 2 (2010) | EFFICACY AND SAFETY OF THERAPY WITH ATORVASTATIN IN HIGH DOSES | Abstract similar documents |
| A. N. Meshkov | ||
| "... is more effective than standard therapy for prevention of cardiovascular complications. Atorvastatin ..." | ||
| Vol 7, No 1 (2011) | SUPPRESSION OF RENIN-ANGIOTENSIN SYSTEM TO PREVENT COMPLICATIONS OF CARDIOVASCULAR DISEASES: CURRENT "ROLES" DISTRIBUTION FROM CLINICAL PHARMACOLOGIST’S POINT OF VIEW | Abstract similar documents |
| S. R. Gilyarevskiy, V. A. Orlov, M. V. Golshmid, G. Yu. Zakharova, I. I. Sinitsina | ||
| "... of ACE inhibitor choice is also discussed in context of secondary prevention of cardiovascular ..." | ||
| Vol 19, No 5 (2023) | Gender and age features of dyslipidemia in the population of the Nizhny Novgorod region | Abstract similar documents |
| N. Yu. Borovkova, V. K. Kurashin, A. S. Tokareva, T. E. Bakka, N. K. Pershina, E. S. Timoshchenko, A. A. Nekrasov, E. A. Ovchinnikova, N. N. Savickaya, M. A. Mironov, Yu. A. Balanova, A. E. Imaeva, A. V. Kontsevaya | ||
| "... ,9%, a HTG — in 42,6%, a reduced level of HDL-C — in 13,3%. The data obtained determine a high cardiovascular ..." | ||
| Vol 8, No 6 (2012) | SECONDARY PHARMACOLOGICAL PREVENTION OF CARDIOVASCULAR DISEASES: OUR ABILITY IN CLINICAL PRACTICE | Abstract similar documents |
| E. V. Filippov, S. S. Yakushin | ||
| "... The most pressing issues of the secondary drug prevention of the most common cardiovascular ..." | ||
| Vol 12, No 5 (2016) | The Value of Subclinical Carotid Atherosclerosis for Primary Prevention of Cardiovascular Diseases. Review of the Main International Studies | Abstract similar documents |
| E. K. Butina, E. V. Bochkareva | ||
| "... Measures for the prevention of cardiovascular diseases (CVD) are more effective ..." | ||
| Vol 7, No 4 (2011) | METHODS OF ASSISTANCE FOR SMOKING CESSATION IN INTERNATIONAL CLINICAL RECOMMENDATIONS FOR TREATMENT AND PREVENTION OF CARDIOVASCULAR DISEASE | Abstract similar documents |
| M. S. Berezhnova | ||
| "... is presented. Particular attention is paid to the recommendations for treatment and prevention ..." | ||
| Vol 10, No 5 (2014) | STATINS IN THE TREATMENT AND PREVENTION OF CARDIOVASCULAR DISEASES: REPETITION OF THE PAST AND OPTIMISM FOR THE FUTURE | Abstract similar documents |
| L. N. Malay | ||
| "... for the treatment and prevention of cardiovascular diseases caused by atherosclerosis. The milestones of lipid ..." | ||
| Vol 1, No 3 (2005) | EDITORIAL COMMENTS ON “EUROPEAN GUIDELINES ON CARDIOVASCULAR DISEASE PREVENTION IN CLINICAL PRACTICE” | Abstract similar documents |
| "... Editorial comments on “european guidelines on cardiovascular disease prevention in clinical ..." | ||
| Vol 8, No 4 (2012) | EFFECT OF CARDIOVASCULAR DRUGS ON BONE HEALTH AND THE POSSIBILITY OF THEIR USE FOR THE PREVENTION OF OSTEOPOROSIS | Abstract similar documents |
| I. A. Skripnikova, K. E. Sobchenko, O, V. Kosmatova, D. V. Nebieridze | ||
| "... to recommend discussed cardiovascular drugs for prevention of osteoporosis and fractures, as well ..." | ||
| Vol 8, No 2 (2012) | EFFICACY AND SAFETY OF ACETYLSALICYLIC ACID IN PRIMARY AND SECONDARY PREVENTION OF CARDIOVASCULAR DISEASES | Abstract similar documents |
| S. N. Tolpygina, S. Yu. Martsevich, E. N. Khoseva, N. V. Kiseleva | ||
| "... Acetylsalicylic acid (ASA) use in the primary and secondary prevention of cardiovascular diseases ..." | ||
| Vol 2, No 3 (2006) | APPLICATION OF CALCIUM ANTAGONISTS IN PREVENTION OF CARDIOVASCULAR COMPLICATIONS DURING CARDIAC SURGERY | Abstract similar documents |
| S. V. Nedogoda | ||
| Vol 4, No 3 (2008) | COMMENTS ON EUROPEAN GUIDELINES ON CARDIOVASCULAR DISEASE PREVENTION IN CLINICAL PRACTICE | Abstract similar documents |
| S. A. Shalnova | ||
| Vol 15, No 4 (2019) | The Association of Smoking Status and Intensity of Smoking with Blood Lipid Spectrum in a Sample of Middle-Aged Men | Abstract similar documents |
| A. A. Alexandrov, V. B. Rozanov, M. B. Kotova, V. A. Dadaeva, E. I. Ivanova | ||
| "... Material and methods. A 32-year prospective cohort follow-up of males from childhood (11-12 years ..." | ||
| Vol 11, No 6 (2015) | The influence of concomitant diseases on a long-term prognosis in patients with chronic ischemic heart disease according to the PROGNOZ IBS register | Abstract similar documents |
| S. N. Tolpygina, S. Yu. Martsevich, A. D. Deev | ||
| "... that were complications of IHD were considered as comorbidities as well as not cardiovascular diseases ..." | ||
| Vol 13, No 3 (2017) | SECONDARY PREVENTION OF CARDIOVASCULAR DISEASES AMONG PATIENTS OF DIFFERENT AGE GROUPS WITH A HISTORY OF MYOCARDIAL INFARCTION BY THE EXAMPLE OF OUTPATIENT CARDIOLOGY INSTITUTION | Abstract similar documents |
| S. B. Fitilev, D. A. Dimitrova, I. I. Shkrebneva, A. V. Vozzhaev | ||
| "... Aim. To study secondary prevention of cardiovascular diseases among patients of different age ..." | ||
| Vol 11, No 3 (2015) | EVALUATION OF THE CONFORMITY OF CARDIOVASCULAR THERAPY TO CURRENT CLINICAL GUIDELINES IN THE IMPROVEMENT OF OUTCOMES IN PATIENTS AFTER STROKE (ACCORDING TO THE LIS-2 REGISTER) | Abstract similar documents |
| A. Yu. Suvorov, S. Yu. Martsevich, N. P. Kutishenko, A. D. Deev, M. L. Ginzburg, A. V. Akimova, E. V. Daniels, A. V. Fokina, N. A. Dmitrieva, L. Yu. Drozdova, N. Yu. Zhuravskaya, O. V. Lerman, Yu. V. Lukina, M. M. Loukianov | ||
| "... cerebral stroke). Material and methods. The scales to assess the quality of cardiovascular care ..." | ||
| Vol 4, No 1 (2008) | WHAT CAN WE EXPECT USING ACE INHIBITOR RAMIPRIL IN PERSONS WITH HIGH CARDIOVASCULAR RISK AND EARLY DISORDERS OF CARBOHYDRATE METABOLISM? LESSONS OF DREAM TRIAL | Abstract similar documents |
| M. N. Mamedov, M. B. Stroeva | ||
| "... Primary prevention of diabetes in persons with high cardiovascular risk is an actual problem ..." | ||
| Vol 13, No 6 (2017) | SMOKING AS A RISK FACTOR OF CARDIOVASCULAR AND CEREBROVASCULAR DISEASES: PREVALENCE, IMPACT ON PROGNOSIS, POSSIBLE SMOKING CESSATION STRATEGIES AND THEIR EFFECTIVENESS. Part 1. Smoking Prevalence and Impact on Prognosis | Abstract similar documents |
| O. D. Ostroumova, A. A. Izvekov, N. Yu. Voevodina | ||
| "... heart disease (IHD); cerebral circulation disorders; lower respiratory tract infection; chronic ..." | ||
| Vol 7, No 6 (2011) | EFFICACY OF CORONARY STENTING AND BASIC PHARMACOTHERAPY IN ELDERLY AND SENILE PATIENTS: THE RESULTS OF LONG-TERM PROSPECTIVE FOLLOW-UP | Abstract similar documents |
| L. R. Mirzakhanova | ||
| "... heart disease (IHD) were included into the study. Coronary stenting with the subsequent basic ..." | ||
| Vol 18, No 2 (2022) | Sequelae of COVID-19 at long-term follow-up after hospitalization | Abstract PDF (Eng) similar documents |
| N. V. Pogosova, F. N. Paleev, A. K. Ausheva, D. T. Kuchiev, S. A. Gaman, T. N. Veselova, M. B. Belkind, O. Yu. Sokolova, R. A. Zhetisheva, S. K. Ternovoy, S. A. Boytsov | ||
| "... of Russia from April to June 2020 were invited to participate in a follow-up study. At 3-7 months after ..." | ||
| Vol 6, No 4 (2010) | ECONOMIC EFFICIENCY OF THE IMPLEMENTATION OF THE PROGRAM OF CARDIOVASCULAR DISEASES MULTIFACTORIAL PREVENTION IN THE ORGANIZED COLLECTIVE OF TECHNICAL RESEARCH INSTITUTE | Abstract similar documents |
| A. V. Kontsevaya, A. M. Kalinina, S. V. Belonosova, J. M. Pozdnjakov, M. B. Khudyakov | ||
| "... in control group. Conclusion. Implementation of cardiovascular diseases prevention at workplace ..." | ||
| Vol 8, No 1 (2012) | PRIMARY PREVENTION OF DIABETES MELLITUS: CORRECTION OF EARLY DISORDERS OF GLUCOSE METABOLISM IN CARDIOLOGY PRACTICE | Abstract similar documents |
| M. N. Mamedov, E. A. Poddubskaya, M. N. Kovrigina, Z. O. Ugurchieva, R. T. Digigova | ||
| "... are an independent risk factor for cardiovascular disease. The possibilities of GMD prevention and early treatment ..." | ||
| Vol 9, No 4 (2013) | ACETYLSALICYLIC ACID: CONTROVERSIAL AND OUTSTANDING ISSUES | Abstract similar documents |
| E. N. Dankovtseva | ||
| "... Review of current ideas about the role of acetylsalicylic acid (ASA) in the primary prevention ..." | ||
| Vol 20, No 5 (2024) | Lipoprotein(a), atherosclerosis and cardiovascular risk | Abstract similar documents |
| E. A. Polyakova, Iu. S. Khalimov, E. A. Bazhenova, T. M. Bakher | ||
| "... lipoprotein(a) (Lp(a)) as a new target for the diagnosis, prevention and pharmacotherapy of atherosclerotic ..." | ||
| Vol 9, No 3 (2013) | NICOTINE REPLACEMENT THERAPY OF THE TOBACCO ADDICTION IN PREVENTION OF CARDIORESPIRATORY DISEASES | Abstract similar documents |
| M. G. Gambaryan | ||
| "... of cardiorespiratory diseases. Smoking cessation is the most cost-effective measure for prevention of cardiovascular ..." | ||
| Vol 10, No 2 (2014) | STUDY OF URSODEOXYCHOLIC ACID INFLUENCE ON EFFICACY AND SAFETY OF STATIN THERAPY IN PATIENTS WITH DISEASES OF THE LIVER, GALL BLADDER AND/OR BILIARY TRACT (THE RAKURS STUDY) | Abstract similar documents |
| S. Yu. Martsevich, N. P. Kutishenko, L. Yu. Drozdova, O. V. Lerman, V. A. Nevzorova, I. I. Reznik, G. V. Shavkuta, D. A. Yahontov | ||
| "... prevention of CVE in observational cohort study. The follow-up duration was 6 months. UDCA was recommended ..." | ||
| Vol 21, No 2 (2025) | Refusal of pharmacological treatment: prevalence and clinical importance | Abstract similar documents |
| S. Yu. Martsevich, N. P. Kutishenko, E. P. Kalaydzhyan, Yu. V. Lukina, A. V. Zagrebelnyy, V. V. Tsaregorodtseva, O. S. Afonina, N. P. Zolotareva, M. L. Ginzburg, O. M. Drapkina | ||
| "... diseases, particularly those with cardiovascular conditions, are rare. Most of these studies examine ..." | ||
| Vol 15, No 6 (2019) | Outpatient Registry REGION: Prospective Follow-up Data and Outcomes in Patients After Acute Cerebrovascular Accident | Abstract similar documents |
| M. M. Loukianov, S. S. Yakushin, S. Yu. Martsevich, A. N. Vorobyev, K. G. Pereverzeva, E. Yu. Okshina, A. V. Zagrebelnyy, V. G. Klyashtorny, E. V. Kudryashov, S. A. Boytsov, O. M. Drapkina | ||
| "... Aim. To estimate outcomes and risk of all-cause mortality, cardiovascular (CV) mortality, and non ..." | ||
| Vol 9, No 1 (2013) | OUTPATIENT REGISTER OF CARDIOVASCULAR DISEASES IN THE RYAZAN REGION (RECVASA): PRINCIPAL TASKS, EXPERIENCE OF DEVELOPMENT AND FIRST RESULTS | Abstract PDF (Eng) similar documents |
| S. A. Boytsov, S. S. Yakushin, S. Yu. Martsevich, M. M. Lukyanov, N. N. Nikulina, A. V. Zagrebelny, A. N. Vorobyov, K. G. Pereverseva, E. A. Pravkina, A. D. Deev, E. Yu. Andreenko, A. I. Ershova, A. N. Meshkov, R. P. Myasnikov, S. E. Serdyuk, М. S. Kharlap | ||
| "... %) in patients with hypertension, IHD, CHF and AF, insufficient estimation of cardiovascular risk factors ..." | ||
| Vol 4, No 3 (2008) | EUROPEAN GUIDELINES ON CARDIOVASCULAR DISEASE PREVENTION IN CLINICAL PRACTICE FOURTH JOINT TASK FORCE OF THE EUROPEAN SOCIETY OF CARDIOLOGY AND OTHER SOCIETIES ON CARDIOVASCULAR DISEASE PREVENTION IN CLINICAL PRACTICE . | Abstract similar documents |
| I. Graham, D. Atar, K. Borch-Johnsen, G. Boysen, G. Burell, R. Cifkova, J. Dallongeville, G. De Backer, S. Ebrahim, B. Gjelsvik, C. Herrmann-Lingen, A. Hoes, S. Humphries, M. Knapton, J. Perk, S. G. Priori, K. Pyorala, Z. Reiner, L. Ruilope, S. Sans-Menendez, W. Scholte op Reimer, P. Weissberg, D. Wood, J. Yarnell, J. L. Zamorano | ||
| "... Society of Cardiology (ESC), в состав которого входят European Association for Cardiovascular Prevention ..." | ||
| Vol 7, No 6 (2011) | DETERMINANTS OF PREVENTIVE BEHAVIOR REGARDING CARDIOVASCULAR DISEASES AND RISK FACTORS IN PATIENTS WITH ESSENTIAL HYPERTENSION AND CHRONIC ISCHEMIC HEART DISEASE | Abstract similar documents |
| D. Yu. Platonov, T. A. Kostjuk, A. I. Brandt, O. V. Tsygankova | ||
| "... logistic regression. Results. Awareness of the cardiovascular diseases (CVD) and its prevention (odds ratio ..." | ||
| Vol 5, No 6 (2009) | STATIN GENERICS: EFFICACY AND SAFETY RATIO | Abstract similar documents |
| V. P. Voronina, A. A. Serazhim, A. V. Zagrebelnyi, S. Yu. Martsevich, S. A. Shalnova | ||
| "... Statin usage for primary and secondary prevention of cardiovascular diseases is focused. Rational ..." | ||
| Vol 16, No 4 (2020) | Felodipine in Treatment of Arterial Hypertension and Ischemic Heart Disease | Abstract similar documents |
| O. D. Ostroumova, I. A. Alautdinova, A. I. Kochetkov, S. N. Litvinova | ||
| "... Cardiovascular diseases are the leading cause of death both in the world and in the Russian ..." | ||
| Vol 4, No 4 (2008) | EUROPEAN GUIDELINES ON CARDIOVASCULAR DISEASE PREVENTION IN CLINICAL PRACTICE (ENDING). FOURTH JOINT TASK FORCE OF THE EUROPEAN SOCIETY OF CARDIOLOGY AND OTHER SOCIETIES ON CARDIOVASCULAR DISEASE PREVENTION IN CLINICAL PRACTICE | Abstract similar documents |
| I. Graham, D. Ata, K. Borch-Johnsen, G. Boysen, G. Burell, R. Cifkova, J. Dallongeville, G. De Backe, Sh. Ebrahim, B. Gjelsvik, Ch. Herrmann-Lingen, A. Hoes, S. Humphries, M. Knapton, J. Perk, S. G. Priori, K. Pyorala, Z. Reiner, L. Ruilope, S. Sans-Menendez, W. Scholte op Reime, P. Weissberg, D. Wood, J. Yarnell, J. L. Zamorano | ||
| Vol 12, No 5 (2016) | Statins in Secondary Prevention of Atrial Fibrillation | Abstract similar documents |
| V. I. Podzolkov, A. I. Tarzimanova, R. G. Gataulin | ||
| "... patients with paroxysmal atrial fibrillation (AF) in the longterm follow-up. Material and methods ..." | ||
| Vol 19, No 1 (2023) | Microbiota and Cardiovascular Diseases: Mechanisms of Influence and Correction Possibilities | Abstract similar documents |
| A. V. Gorbenko, Y. P. Skirdenko, K. A. Andreev, M. M. Fedorin, N. A. Nikolaev, M. A. Livzan | ||
| "... types. The link between the gut microbiota and cardiovascular disease (CVD) is being actively ..." | ||
| Vol 16, No 1 (2020) | Alirocumab Administration Experience to Achieve Low Density Lipoprotein Cholesterol Target Levels in Secondary Prevention of Cardiovascular Disease | Abstract similar documents |
| A. E. Nikitin, E. E. Averin, D. E. Rozhkov, A. V. Sozykin, G. A. Procenko | ||
| "... , alirocumab, on lipid levels in patients who receive secondary prevention of cardiovascular diseases (CVD ..." | ||
| Vol 16, No 3 (2020) | On the Quality of Medical Examination: Diagnostic Significance of the Survey Method for Detecting the Probability of Cardio-Cerebral Symptoms | Abstract similar documents |
| A. M. Kalinina, K. A. Antonov, B. E. Gornyi, I. I. Dubovoj, O. M. Drapkina | ||
| "... the point of view of timely prevention. Neurological symptoms according to the automated survey were ..." | ||
| Vol 17, No 2 (2021) | Features of Risk Stratification, Diagnosis and Secondary Prevention in Patients with Multifocal Arterial Disease. Part 2: Treatment Options | Abstract similar documents |
| V. G. Grachev, S. S. Vedenskaya, O. G. Smolenskaya | ||
| "... , regardless of their location, makes the approaches to secondary prevention similar, which include lifestyle ..." | ||
| Vol 17, No 1 (2021) | Features of Risk Stratification, Diagnosis and Secondary Prevention in Patients with Multifocal Arterial Disease. Part 1: Risk Stratification and Diagnosis | Abstract similar documents |
| V. G. Grachev, S. S. Vedenskaya, O. G. Smolenskaya | ||
| "... Multifocal arterial disease is common in patients with atherosclerotic cardiovascular disease ..." | ||
| Vol 20, No 2 (2024) | Comparative placebo-controlled study on the effect of dietary supplements containing omega-3 polyunsaturated fatty acids on hemodynamics and lipid metabolism in postmenopausal women | Abstract similar documents |
| D. A. Napalkov, A. A. Sokolova, A. A. Kudrjavtseva, A. I. Skripka, A. V. Zhilenko, E. V. Kolpachkova, D. K. Varvarina | ||
| "... postmenopausal women with a mean age of 55.9±6.0 years, without cardiovascular complications, type 2 diabetes ..." | ||
| Vol 10, No 4 (2014) | DIAGNOSTICS, TREATMENT, ASSOCIATED CARDIOVASCULAR AND CONCOMITANT NON-CARDIAC DISEASES IN PATIENTS WITH DIAGNOSIS OF “ATRIAL FIBRILLATION” IN REAL OUTPATIENT PRACTICE (ACCORDING TO DATA OF REGISTRY OF CARDIOVASCULAR DISEASES, RECVASA) | Abstract PDF (Eng) similar documents |
| M. M. Loukianov, S. A. Boytsov, S. S. Yakushin, S. Yu. Martsevich, A. N. Vorobyev, A. V. Zagrebelnyy, M. S. Kharlap, K. G. Pereverzeva, E. A. Pravkina, S. E. Serdyuk, A. D. Deev, E. N. Kudryashov | ||
| "... associated cardiovascular diseases (HT and/or IHD and/or CHF). The history of myocardial infarction, stroke ..." | ||
| Vol 9, No 4 (2013) | NORVASC® IN RUSSIA 20 YEARS LATER: CONTINUATION OF THE HISTORY | Abstract similar documents |
| A. V. Rudenko, B. A. Rudenko | ||
| "... for treatment of hypertensive patients. This is particularly important for the primary prevention ..." | ||
| Vol 14, No 6 (2018) | Cardiovascular Diseases and Drug Treatment in Patients with the History of Cerebral Stroke: Data of the Outpatient Registry REGION | Abstract PDF (Eng) similar documents |
| M. M. Loukianov, S. S. Yakushin, S. Yu. Martsevich, O. M. Drapkina, A. N. Vorobyev, A. V. Zagrebelnyy, A. N. Kozminsky, K. A. Moseichuk, K. G. Pereverzeva, E. A. Pravkina, E. Yu. Okshina, E. V. Kudryashov, E. N. Belova, V. G. Klyashtorny, S. A. Boytsov | ||
| "... of patients with a history of stroke, as well as prevention of cardiovascular complications. ..." | ||
| Vol 5, No 3 (2009) | RISK FACTORS OF THE ERECTILE DYSFUNCTION IN THE PATIENTS WITH CARDIOVASCULAR DISEASES | Abstract similar documents |
| E. V. Minakov, R. A. Khokhlov, T. N. Kuznetsova, Y. V. Popovskaya, D. V. Snustikov, E. E. Tsareva, V. I. Yarliykova, N. M. Akhmedzhanov | ||
| "... patients with HT and/or CHD. Early erectile dysfunction diagnosis, prevention and therapy are necessary ..." | ||
| Vol 16, No 4 (2020) | Inhibitors in the Management of Patients with Atherosclerotic Cardiovascular Diseases: Guidelines and Reimbursement Issues | Abstract similar documents |
| M. V. Zhuravleva, A. B. Prokofiev, E. V. Shikh, S. Yu. Serebrova, G. I. Gorodetskaya, E. Yu. Demchenkova | ||
| "... in a significant proportion of patients with atherosclerotic cardiovascular diseases (ACVD) is impossible ..." | ||
| Vol 21, No 2 (2025) | A randomized controlled trial of statin therapy effect on androgen status and erectile function in men with high and very high cardiovascular risk (TRISTAN): rationale and study protocol | Abstract similar documents |
| K. P. Raevskii, O. Yu. Nesterova, A. A. Strigunov, M. E. Chaliy, A. V. Kadrev, A. G. Plisyuk, A. A. Kamalov, Ya. A. Orlova | ||
| "... the effectiveness of prevention of cardiovascular events. ..." | ||
| Vol 9, No 5 (2013) | TREATMENT OF PATIENTS WITH CHRONIC ISCHEMIC HEART DISEASE IN REAL CLINICAL PRACTICE ACCORDING TO THE DATA FROM PROGNOZ IBS REGISTER (PART 2) | Abstract similar documents |
| S. N. Tolpygina, Yu. N. Polyanskaya, S. Yu. Martsevich | ||
| "... prescription frequency of drugs with proven effects on the cardiovascular risk in patients with stable IHD ..." | ||
| Vol 12, No 3 (2016) | EFFICACY AND SAFETY OF LIPID-LOWERING DRUGS IN PRIMARY AND SECONDARY PREVENTION OF CARDIOVASCULAR DISEASES IN THE ELDERLY | Abstract PDF (Eng) similar documents |
| E. A. Ushkalova, O. N. Tkacheva, N. K. Runikhina, N. A. Chukhareva, A. Yu. Bevz | ||
| "... cover issues of efficacy and safety of lipid-lowering therapy in primary and secondary prevention ..." | ||
| Vol 5, No 1 (2009) | UP TO DATE INFORMATION FOR LEADING CARDIOLOGISTS AND THERAPEUTISTS ABOUT LATEST PREVENTION AND THERAPY METHODS REDUCES GROWTH RATE OF CARDIOVASCULAR DISEASES | Abstract similar documents |
| E. Aleeva | ||
| "... Up to date information for leading cardiologists and therapeutists about latest prevention ..." | ||
| Vol 6, No 5 (2010) | FIXED LOW-DOSE COMBINATION OF LISINOPRIL AND HYDROCHLOROTHIAZIDE IN THE PREVENTION OF CARDIOVASCULAR EVENTS IN HYPERTENSIVE PATIENTS | Abstract similar documents |
| A. O. Shevchenko, O. P. Shevchenko | ||
| Vol 16, No 3 (2020) | The Role of Magnesium in the Development of Cardiovascular Diseases and the Possibility of their Prevention and Correction with Magnesium Preparations (Part 2) | Abstract similar documents |
| A. S. Safaryan, V. S. Sargsyan, D. V. Nebieridze | ||
| "... Data on the effect of magnesium on the homeostasis of the body and on the cardiovascular system ..." | ||
| Vol 10, No 6 (2014) | THE SIGNIFICANCE OF PLATELET FUNCTIONAL ACTIVITY TESTING IN THE PREVENTION OF CARDIOVASCULAR COMPLICATIONS IN PATIENTS RECEIVING ANTIPLATELET THERAPY | Abstract similar documents |
| D. A. Andreev | ||
| "... Council on the significance of testing of platelet functional activity in the prevention of cardiovascular ..." | ||
| Vol 15, No 5 (2019) | The Role of Magnesium in the Development of Cardiovascular Diseases and the Possibility of their Prevention and Correction with Magnesium Preparations (Part 1) | Abstract similar documents |
| A. S. Safaryan, V. S. Sargsyan, T. V. Kamyshova, N. M. Akhmedzhanov, D. V. Nebieridze, E. A. Poddubskaya | ||
| "... and, in particular, on the cardiovascular system. It describes the importance of the presence and effects ..." | ||
| Vol 17, No 1 (2021) | Basic Aspects of Seasonal Cardiovascular Mortality | Abstract similar documents |
| G. F. Andreeva, V. M. Gorbunov | ||
| "... , the main ways of development and prevention of seasonal CV cardiovascular mortality M, taking into account ..." | ||
| Vol 16, No 4 (2020) | Studying the Possibility of Optimizing the Statin Therapy Algorithm in Outpatient Practice | Abstract similar documents |
| D. V. Nebieridze, N. M. Akhmedzhanov, S. A. Davitashvili, A. S. Lishuta, A. S. Safaryan | ||
| "... the possible benefits of statin therapy in fixed doses for primary and secondary prevention of cardiovascular ..." | ||
| Vol 8, No 5 (2012) | ACETYLSALICYLIC ACID: DO WE KNOW EVERYTHING ABOUT IT AND ITS PROPER USE? | Abstract similar documents |
| S. A. Boldueva, I. A. Leonova | ||
| "... and the main indications are discussed. ASA use for primary cardiovascular diseases prevention and its possible ..." | ||
| Vol 12, No 3 (2016) | REPORT ON THE ROUND-TABLE MEETING: "REGISTERS IN CARDIOLOGY: THE BASIC RULES OF MANAGEMENT, MODERN EXPERIENCE AND THE RESULTS OF THEIR CREATION IN THE VARIOUS REGIONS OF THE RUSSIAN FEDERATION" | Abstract PDF (Eng) similar documents |
| S. Yu. Martsevich, M. M. Loukianov, N. P. Kutishenko | ||
| "... of various cardiovascular diseases (CVD) were among participants of the meeting. The importance of modern ..." | ||
| Vol 15, No 4 (2019) | Evidence, Guidelines and Treatment Algorithms for Patients with Arterial Hypertension and Dyslipidemia: the Need for Compromise and Optimization of Tactics in Practical Healthcare | Abstract similar documents |
| O. M. Drapkina, M. V. Ezhov, S. R. Gilyarevsky, R. N Shepel | ||
| "... of cardiovascular complications for primary prevention in a wide population are presented. The question of the ratio ..." | ||
| Vol 19, No 2 (2023) | Antithrombotic Therapy in Patients with Paroxysmal Atrial Fibrillation after Catheter Treatment | Abstract similar documents |
| O. R. Eshmatov, M. S. Khlynin, R. E. Batalov, E. A. Archakov, I. V. Kisteneva | ||
| "... fibrillation (AF) after catheter treatment during 36 months of follow-up. Material and methods ..." | ||
| Vol 11, No 2 (2015) | LOW SODIUM DIET: PROS AND CONS | Abstract similar documents |
| O. M. Drapkina, R. N. Shepel' | ||
| "... for the prevention of various diseases. At that, it is a generally accepted fact, that it is necessary to reduce salt ..." | ||
| Vol 9, No 1 (2013) | CLINICAL AND COST EFFECTIVENESS OF PREVENTIVE COUNSELING OF YOUNG PATIENTS WITH ARTERIAL HYPERTENSION IN PRIMARY HEALTH CARE | Abstract similar documents |
| M. I. Shupina, O. Ju. Korennova, E. N. Loginova | ||
| "... consultation. Clinical and cost analysis was performed in 6, 12 and 36 months of the follow-up. Results ..." | ||
| Vol 14, No 5 (2018) | Economic losses due to low coverage of lipid-lowering therapy in patients with cardiovascular diseases in the Russian Federation | Abstract similar documents |
| Yu. A. Balanova, A. V. Kontsevaya, A. E. Imaeva, O. I. Karpov, M. B. Khudyakov | ||
| "... ) in patients with cardiovascular diseases (CVD) and hypercholesterolemia (HCS) in the Russian population ..." | ||
| Vol 12, No 2 (2016) | CORRELATIONS OF DIFFERENT STRUCTURAL AND FUNCTIONAL CHARACTERISTICS OF ARTERIAL WALL WITH TRADITIONAL CARDIOVASCULAR RISK FACTORS IN HEALTHY PEOPLE OF DIFFERENT AGE. PART 1 | Abstract PDF (Eng) PDF (Eng) similar documents |
| I. D. Strazhesko, O. N. Tkacheva, D. U. Akasheva, E. V. Dudinskaya, M. V. Agaltsov, A. S. Kruglikova, N. V. Brailova, V. S. Pykhtina, E. V. Plokhova, N. V. Sharashkina, O. Yu. Isaykina, V. A. Vygodin, S. A. Boytsov | ||
| "... Arterial wall status is determined by several characteristics, the main of them are as follows ..." | ||
| Vol 12, No 3 (2016) | PRACTICE OF PRESCRIBING BETA-BLOCKERS AND ITS COMPLIANCE WITH CLINICAL GUIDELINES ACCORDING TO TWO REGISTERS OF CARDIOVASCULAR DISEASES | Abstract PDF (Eng) similar documents |
| S. Yu. Martsevich, N. A. Zakharova, N. P. Kutishenko, A. V. Zagrebelnyy, A. V. Zakharova, M. M. Loukianov, A. N. Vorobyev, K. A. Moseichuk, A. N. Kozminsky | ||
| "... disease (IHD), chronic heart failure (CHF) and atrial fibrillation (AF) that consulted in 3 outpatient ..." | ||
| Vol 13, No 1 (2017) | THE STUDY "REGISTER OF PATIENTS AFTER ACUTE STROKE (REGION)". PART 2. OUTPATIENT PROSPECTIVE REGISTER OF PATIENTS AFTER ACUTE STROKE (ACCORDING TO THE RESULTS OF THE PILOT PHASE OF THE STUDY) | Abstract PDF (Eng) similar documents |
| S. А. Boytsov, M. M. Loukianov, S. S. Yakushin, S. Yu. Martsevich, L. V. Stakhovskaya, A. N. Vorobyev, A. V. Zagrebelnyy, N. P. Kutishenko, A. N. Kozminsky, K. A. Moseichuk, K. G. Pereverzeva, E. A. Pravkina, E. N. Belova, E. V. Kudryashov, A. D. Deev | ||
| "... , concomitant cardiovascular diseases (CVD) and noncardiac diseases were analyzed. We estimated accordance ..." | ||
| 1 - 100 of 953 Items | 1 2 3 4 5 6 7 8 9 10 > >> | |
Search tips:
- Search terms are case-insensitive
- Common words are ignored
- By default articles containing any term in the query are returned (i.e., OR is implied)
- Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
- Combine multiple words with AND to find articles containing all terms; e.g., education AND research
- Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
- Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
- Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)
